Employees: 242
Size Lifenet Insurance (7157.T) is a Japan Financials company (Life/Health Insurance) with a market value of $710M, the 899th largest of 1,379 Japan companies the cockpit tracks. Shares closed at ¥1,393 on 6 Nov 2026.
Performance Over six months the shares fell 27.5%, against -5.8% for the median peer and +1.8% for the Japan market (cap-weighted) — 3rd lowest of 11 in its peer set.
Growth Revenue grew 12.3% over the last twelve months (peer median +17.5%); the operating margin is 30.6% (peer median 1.6%).
Valuation It trades at 1.18× book value against a peer median of 0.82× (5th most expensive of 11).
Price implies The share price implies a return on equity of about 7.0%; Lifenet Insurance delivers 7.9%, so the price asks less than the business earns today.
Next results Next results expected around 12 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ¥36.6B | ¥35.6B | ¥31.1B | ¥25.1B | ¥21.0B |
| Revenue growth | — | +15% | +23% | +20% | — |
| Net income | ¥7.50B | ¥8.04B | ¥5.99B | ¥5.73B | ¥3.56B |
| Free cash flow | n/a | ¥7.99B | ¥6.10B | ¥5.23B | ¥2.03B |
| Capital expenditure | n/a | ¥830M | ¥1.18B | ¥783M | ¥650M |
| Total debt | ¥942M | ¥1.01B | ¥1.29B | ¥110M | ¥255M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 7157.T | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -7.4% | -1.6% | 5th lowest of 11 |
| 6-month return | -27.5% | -5.8% | 3rd lowest of 11 |
| Return on equity | 7.9% | 6.9% | 4th highest of 11 |
| Price / book | 1.18× | 0.82× | 5th most expensive of 11 |
| Trailing P/E | 14.9× | 9.8× | 5th most expensive of 10 |
| ROE the price implies | 7.0% | 5.8% | 5th most demanding of 11 |
| ROE delivered | 7.9% | 6.9% | 4th highest of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| Lifenet Insurance 7157.T | Japan | $710M | -28% | +12% | 8% | 1.18× | 7.0% | 7.9% |
| Farglory Life Insurance 5859.TWO | Taiwan | $625M | -7% | -48% | 7% | 0.23× | 1.7% | 7.1% |
| Mercuries & Associates 2905.TW | Taiwan | $561M | +30% | -6% | 5% | 0.22× | 1.8% | 5.1% |
| Yunfeng Financial 0376.HK | Hong Kong | $999M | -30% | +21% | 7% | 0.60× | 7.8% | 6.7% |
| Canara HSBC Life Insurance CANHLIFE.NS | India | $1.23B | -14% | +17% | 8% | 7.08× | 48.0% | 8.2% |
| Niva Bupa Health Insurance NIVABUPA.NS | India | $1.49B | -5% | +58% | 14% | 3.66× | 33.1% | 13.9% |
| Nuernberger Beteiligungs NBG6.DE | Germany | $1.58B | +1% | -1% | 5% | 1.58× | 6.0% | 5.1% |
| Mirae Asset Life Insurance 085620.KS | South Korea | $1.78B | +17% | +22% | 5% | 1.05× | 5.6% | 5.2% |
| Hanwha Life 088350.KS | South Korea | $2.16B | -20% | +18% | 8% | 0.22× | 3.8% | 7.7% |
| Brighthouse Financial BHF | United States | $2.45B | -31% | +3% | 14% | 0.37× | 5.2% | 13.6% |
| Clover Health Investments CLOV | United States | $2.56B | +54% | +54% | -5% | 6.32× | 94.7% | -5.1% |